The global Active Pharmaceutical Ingredients (API) market, valued at US$ 250.9 Bn in 2024, is projected to grow at a CAGR of 5.8% during the forecast period from 2025 to 2035 and surpass US$ 466.9 Bn by 2035. The market is poised for robust expansion due to rising chronic and infectious disease burdens, increasing demand for generics, and strong investments in research and development...